Leading With an Eye on the Future of Care

The Fresenius Kabi Executive Leadership Team

Every vision needs a forward-looking leadership team with the power to inspire and push boundaries while being close to all those actively helping realize its implementation. Our Executive Leadership Team is continually striving to advance our shared vision through sound growth strategies, investment in future markets, and personal interaction throughout our global sites. Leading by example with respect and responsibility is at the core all our management’s activities.

Pierluigi Antonelli

President and CEO of Fresenius Kabi

As President and CEO of Fresenius Kabi, Pierluigi Antonelli is at the forefront in helping create and lead the next step in our company's strategic roadmap. During his distinguished career, he has held leading positions at numerous international corporations, including Novartis Oncology, Sandoz, Merck & Co, Bristol-Myers Squibb, McKinsey & Company and as CEO of Angelini Pharma. He holds an MBA from Kellogg School of Management and a degree in Business and Economics from L.U.I.S.S.

At a glance
  • CEO of Fresenius Kabi since March 2023 
  • Over 25 years of management experience 
  • Deep operational expertise in product development and launch of new products in key international markets
Pierluigi Antonelli

Andreas Duenkel

Chief Financial Officer & Chief Compliance Officer

Andreas Duenkel’s experience in international finance leadership spans continents and corporations. Before joining the Management Board, he was Chief Finance Officer for our North American region. As a certified Chartered Accountant, Andreas has honed his strategic business and financial skills with leadership positions at Siemens Healthineers AG, Siemens AG, and at Ernst & Young and Arthur Andersen in the UK.

At a glance
  • CFO of Fresenius Kabi since June 2022 
  • Over 20 years in senior financial roles across healthcare businesses 
  • Extensive expertise in finance transformations 
Andreas Duenkel

Yvonne Albert

Chief Human Resources Officer

Yvonne Albert brings extensive experience and a proven track record in leading and transforming large global organizations. She has held various leadership positions, previous to joining Fresenius Kabi she was heading the HR department for the Life Science sector at Merck KGaA, with key focus on organizational transformation, talent management and capabilities for the future. Through her work and experience in Europe (Germany, France) and the US, she has developed a deep understanding of different cultures and business environments. This experience has enabled her to excel in all core areas of HR, including business partnering, recruiting, compensation, and talent management.

At a glance
  • CHRO of Fresenius Kabi since November 2023
  • In-depth experience in leading and collaborating with teams across the globe
  • Core expertise in Transformation & Change Leadership
Yvonne Albert

Dr. Marc-Alexander Mahl

President Pharma & Nutrition 

Marc Mahl brings a comprehensive portfolio to the Management Board with extensive experience in the pharmaceutical and nutrition industry. His focus is on strategy, development, production, M&A, and reorganization management. Before his current position, he served as Head of Business Unit Generics and IV Fluids EU & RoW of Fresenius Kabi. Marc is a trained physician, specializing in transfusion medicine and holds an eMBA degree from INSEAD. 

At a glance
  • Working at Fresenius since 2001 
  • Gained broad advocacy experience from his role as past President of Medicines for Europe in Brussels
  • Extensive management experience and leadership role in the development and operations of generic drugs and nutrition 
Dr. Marc-Alexander Mahl

Dr. Christian Hauer

President MedTech 

Christian Hauer, became Member of the Fresenius Kabi Management Board in January 2013 and President of Fresenius Kabi MedTech in January 2022 after serving several years as President Medical Devices and President Transfusion Medicine and Cell Therapies. Before joining Fresenius Kabi in 2012 as Head of GBS Medical Devices, he worked for more than 13 years for Drägerwerk AG, where he held various management positions including VP Services USA, President global Sales & Marketing, President Dräger Medical and member of the Executive team of Drägerwerk AG. Christian Hauer holds a master’s degree in business administration and industrial engineering (Wirtschaftsingenieur) and a PhD in industrial engineering from the Technical University Hamburg-Harburg.

At a glance
  • First joined Fresenius in 2012 
  • Held various leading positions in MedTech
  • Pivotal role in successful transformation of the Transfusion Medicine and Cell Therapies business
Dr. Christian Hauer

Dr. Michael Schönhofen

President Biopharma 

Michael Schönhofen, became Member of the Fresenius Kabi Management Board in January 2004, responsible for Operations and Technology. Since then and throughout the years, he has been responsible for different segments and businesses within Fresenius Kabi including having been the COO of Fresenius Kabi. Since May 2023, he is serving as the President Biopharmaceuticals. Before joining Fresenius Kabi in 2004 he worked 13 years for Fresenius Medical Care AG, where he held various management positions including VP Artificial Kidneys and EVP Disposables EU, Latam and Middle East. Michael Schönhofen holds a Diploma degree in Physics and a PhD in Theoretical Nuclear and Elementary Particle Physics from the Technical University Darmstadt.

At a glance
  • First joined Fresenius in 1991 
  • Pivotal role in the development of Fresenius Kabi Biopharma since entering the business in 2017
Dr. Michael Schönhofen

Marc Crouton

President Region Europe

Marc Crouton has taken a major role in the successful development of Fresenius Kabi as member of the Management Board since 1998, with responsibilities on various key sectors and geographies. After managing and developing subsidiaries in France, Spain, Portugal and Italy, he was responsible for the fast international growth of the company in Latin America, Africa, Middle East and Asia including China, through strategic acquisitions and their integration.

At a glance:
  • Working at Fresenius since 1992
  • Joined the Fresenius Kabi Management Board in 1998 as President of Global Fluid Therapy Division
  • President of Region Europe since April 2023
Marc Crouton

John Ducker

President Region U.S.

John Ducker began his career with the Fresenius Group in 1989 and has worked in various international management positions for Fresenius Kabi. Most recently as President Region U.S., John has led commercial strategies in North America, UK, Ireland, Scandinavia, Benelux, Canada and South Africa. He joined the Fresenius Kabi Management Board in 2006 responsible for worldwide R&D, strategic marketing, medical and clinical affairs and regulatory affairs. He also has experience running production facilities. John holds both a first-class Bachelor's degree and Master's degree in Chemical Engineering from Cambridge University.

At a glance
  • President Region US since Jan 2010
  • Over 30 years in senior commercial and strategic roles
  • Extensive expertise in commercial excellence and leadership
John Ducker

Ulf Jansson

Executive Vice President Region Asia Pacific

Ulf Jansson flourishes a genuine global leadership experience in Fresenius Kabi. Having been working abroad for more than 15 years, Ulf has taken C-suites positions to lead the business in regions such as Eastern Europe, Middle East and Africa as well as Asia Pacific. His focus is on strategic development, M&A, organization optimization and development. Ulf holds a master’s degree in Business Administration and Industrial Engineering from the Karlsruhe University of Technology.

At a glance
  • First joined Fresenius in 1999
  • Held various international leadership roles in different geographic regions
  • Pivotal role in strategizing business in Region Asia Pacific for profitable growth 
Ulf Jansson

Alain Mollard

Executive Vice President Region International

Alain Mollard started more than 30 years ago in the French sales organization being for 3 years the General manager of Fresenius Medical care France. In 2001 he moves to Barcelona being the General manager of Fresenius Kabi Spain and EVP of a small region including Spain, Portugal, Greece, and Turkey. In 2003 He takes the responsibility of a new region including Iberia and Latin America developing the region with some important acquisitions. Year after year his region increased the numbers of countries with France, Italy, UK, Belgium, Netherland, Switzerland and Africa. He holds an eMBA from HEC.

At a glance
  • Joined Fresenius in 1992
  • Sales & Marketing background
  • Business knowledge of many countries
Alain Mollard

Eduardo Montanha

Executive Vice President TechOps Pharma and Nutrition

Dr. Matthias Tyssen

Head of Corporate Development, Executive Vice President

Matthias Tyssen brings broad experience in leading and developing key businesses within Fresenius Kabi including our Nutrition, IV Fluids and IV Drugs business. His expertise spans from Portfolio and Project Management, Product and Business Development, Regulatory Affairs, to Marketing. Before joining Fresenius, Matthias gained experience in the Volkswagen Group leading inhouse consulting projects. Matthias holds a diploma degree in business administration and industrial engineering from University of Stuttgart and a Ph.D. in strategic management from EBS Business School.

At a glance

  • Joined Fresenius in 2014 
  • Broad management experience in leadership roles across different business units
  • Pivotal role in the US market entry with a full IV Fluids portfolio and localization of operations 
Matthias Tyssen